首页> 外文OA文献 >Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR
【2h】

Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR

机译:活泼人巨细胞病毒感染在造血干细胞移植(HLA同胞供者)中的监测:通过实时PCR寻找最佳临界值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background: Human cytomegalovirus (CMV) infection still causes significant morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Therefore, it is extremely important to diagnosis and monitor active CMV infection in HSCT patients, defining the CMV DNA levels of virus replication that warrant intervention with antiviral agents in order to accurately prevent CMV disease and further related complications. Methods: During the first 150 days after allogeneic HSTC, thirty patients were monitored weekly for active CMV infection by pp65 antigenemia, nested-PCR and real-time PCR assays. Receiver operating characteristic (ROC) plot analysis was performed to determine a threshold value of the CMV DNA load by real-time PCR. Results: Using ROC curves, the optimal cutoff value by real-time PCR was 418.4 copies/10(4) PBL (sensitivity, 71.4%; specificity, 89.7%). Twenty seven (90%) of the 30 analyzed patients had active CMV infection and two (6.7%) developed CMV disease. Eleven (40.7%) of these 27 patients had acute GVHD, 18 (66.7%) had opportunistic infection, 5 (18.5%) had chronic rejection and 11 (40.7%) died - one died of CMV disease associated with GVHD and bacterial infection. Conclusions: The low incidence of CMV disease in HSCT recipients in our study attests to the efficacy of CMV surveillance based on clinical routine assay. The quantification of CMV DNA load using real-time PCR appears to be applicable to the clinical practice and an optimal cutoff value for guiding timely preemptive therapy should be clinically validated in future studies.
机译:背景:同种异体造血干细胞移植(HSCT)后,人类巨细胞病毒(CMV)感染仍然会导致明显的发病率和死亡率。因此,对HSCT患者的活动性CMV感染进行诊断和监测,确定病毒复制的CMV DNA水平以确保准确地预防CMV疾病和其他相关并发症,必须使用抗病毒药物进行干预,这对诊断和监测其极为重要。方法:在异基因HSTC接种后的头150天内,每周通过pp65抗原血症,巢式PCR和实时PCR分析监测30名患者的活动性巨细胞病毒感染。进行接收器操作特征(ROC)曲线分析,以通过实时PCR确定CMV DNA负载的阈值。结果:使用ROC曲线,实时荧光定量PCR的最佳临界值为418.4拷贝/ 10(4)PBL(敏感性为71.4%;特异性为89.7%)。在30例分析的患者中,有27例(90%)患有活动性巨细胞病毒感染,而2例(6.7%)则患有CMV疾病。这27例患者中有11例(40.7%)患有急性GVHD,18例(66.7%)患有机会性感染,5例(18.5%)患有慢性排斥反应,其中11例(40.7%)死亡-1例死于与GVHD和细菌感染相关的CMV疾病。结论:在我们的研究中,HSCT接受者中CMV疾病的低发生率证明了基于临床常规检测的CMV监测的有效性。使用实时PCR定量检测CMV DNA的量似乎适用于临床实践,用于指导及时的抢先治疗的最佳临界值应在以后的研究中进行临床验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号